ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,555.74
-0.16%
Dow Jones
40,358.09
-0.16%
US Dollar vs MXN
18.21735
0.28%
Brent Oil
80.92
0.18%
Bitcoin
66,490.99
0.86%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
Símbolo desconocido
Fecha:
Ordernar por:
FechaHoraFuenteTítuloSímboloCompañía
24/07/202405:55Business WirePopular Announces Capital ActionsNASDAQ:BPOPPopular Inc
24/07/202405:55Business WireSilgan Announces Agreement to Acquire Weener PackagingNYSE:SLGNSilgan Holdings Inc
24/07/202405:55Business WireVintage Wine Estates, Inc. Announces Bankruptcy Filing and Voluntary Delisting and SEC DeregistrationNASDAQ:VWEVintage Wine Estates Inc
24/07/202405:55Business WireTeledyne Technologies Reports Second Quarter ResultsNYSE:TDYTeledyne Technologies Inc
24/07/202405:55PR Newswire (US)SoCalGas Scholarship Program Awards Over $300,000 to College- and Trade School-Bound StudentsNYSE:SRESempra
24/07/202405:55Business WireSangamo Therapeutics Reports on Pfizer’s Announcement of Positive Topline Results From Phase 3 Trial of Hemophilia A Gene Therapy CandidateNASDAQ:SGMOSangamo Therapeutics Inc
24/07/202405:54Edgar (US Regulatory)Form 8-K - Current reportNYSE:WNCWabash National Corporation
24/07/202405:53Alliance NewsAlliance NewsRUA Life Sciences up on GBP400,000 contract win; annual loss narrowsLSE:RUARua Life Sciences Plc
24/07/202405:53Alliance NewsAlliance NewsCOMMODITIES MARKET: Oil remains under strain; gold up before US data
24/07/202405:53Business WireCD&R et Everest UK HoldCo Limited, une entité contrôlée par les fonds Permira, forment un consortium en vue d'acquérir une participation majoritaire dans Exclusive Networks et déposer une offre publique d'achat obligatoire simplifiéeAMEX:EXNExcellon Resources Inc
24/07/202405:53GlobeNewswire Inc.Wabash Announces Second Quarter 2024 ResultsNYSE:WNCWabash National Corporation
24/07/202405:53Business WireCD&R and Everest UK HoldCo Limited, an Entity Controlled by the Permira Funds, to Form a Consortium to Acquire a Majority Stake in Exclusive Networks and File a Simplified Mandatory Tender OfferAMEX:EXNExcellon Resources Inc
24/07/202405:50GlobeNewswire Inc.Asensus Surgical Announces The Rocky Mountain Hospital for Children in Denver, Colorado to Initiate Senhance Surgery ProgramAMEX:ASXCAsensus Surgical Inc
24/07/202405:50Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:EXKEndeavour Silver Corporation
24/07/202405:50GlobeNewswire Inc.Endeavour Silver provides a Q2 2024 construction progress update on Terronera; the surface construction progress has reached 77% completionTSX:EDREndeavour Silver Corp
24/07/202405:50Business WireSolo Brands, Inc. Second Quarter Fiscal 2024 Financial Results To Be Released Wednesday, August 7, 2024NYSE:DTCSolo Brands Inc
24/07/202405:50PR Newswire (US)CASA NEOS BY RIVIERA DINING GROUP DEBUTS ON THE MIAMI RIVER INTRODUCING LUXURY HOSPITALITY TO THE BLOSSOMING AREA
24/07/202405:49Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNYSE:VSTOVista Outdoor Inc
24/07/202405:49Alliance NewsAlliance NewsTOP NEWS: Thermo Fisher Scientific grows profit amid product launchesLSE:0R0HThermo Fisher Scientific Inc
24/07/202405:48Alliance NewsAlliance NewsEARNINGS PREVIEW: Investors to focus on Anglo American streamliningLSE:AALAnglo American Plc
24/07/202405:48PR Newswire (US)Affirmity Launches a New Dashboard Experience to Provide Next-Gen Analytics and Insights for Affirmative Action Planning
24/07/202405:45Edgar (US Regulatory)Form SC TO-I/A - Tender offer statement by Issuer: [Amend]USOTC:SLRTISila Realty Trust Inc (PK)
24/07/202405:45GlobeNewswire Inc.OKX Wallet Now Integrated with Nubit, a Bitcoin-Native Data Availability Layer
24/07/202405:45Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NYSE:GEVGE Vernova Inc
24/07/202405:45Edgar (US Regulatory)Form IRANNOTICE - Notice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Act Section 13(r)).NYSE:BXMTBlackstone Mortgage Trust Inc
24/07/202405:45Business WireEvercore Reports Second Quarter 2024 Results; Quarterly Dividend of $0.80 Per ShareNYSE:EVREvercore Inc
24/07/202405:45Business WireFerguson Share Repurchase Program - Weekly ReportNYSE:FERGFerguson Plc
24/07/202405:45Business WireOneSpaWorld Announces Second Quarter Fiscal 2024 Financial Results on July 31, 2024NASDAQ:OSWOneSpaWorld Holdings Ltd
24/07/202405:45Business WireTenet Reports Strong Second Quarter 2024 Results; Raises 2024 Financial OutlookNYSE:THCTenet Healthcare Corporation New
24/07/202405:45Business WirePfizer Announces Positive Topline Results From Phase 3 Study of Hemophilia A Gene Therapy CandidateNYSE:PFEPfizer Inc

Su Consulta Reciente

COIN
BTCUSD
Bitcoin
FX
USDMXN
US Dollar vs MXN
NASDAQ
QQQ
Invesco QQQ Trust Series 1
SPI
SP500
S&P 500
AMEX
XLF
Financial Select Sector
NYSE
KO
Coca Cola
FX
EURMXN
Euro vs MXN
CCOM
US30
US 30
NYSE
DIS
Walt Disney
AMEX
XLV
Health Care Select Sector
USOTC
BNPQY
BNP Paribas (QX)
USOTC
RHHBY
Roche (QX)
NYSE
NKE
Nike
NASDAQ
MSFT
Microsoft
USOTC
DTEGY
Deutsche Telekom (QX)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados